LITS — Lite Strategy, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1262104 ·
Last close
$0.92
Market Cap
$31.28M
52W High
$1.26
52W Low
$0.69
ADV30
568,805
Next earnings
2026-05-13
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -2,765,000 | -23,694,000 | 57,789,000 | 7,544,000 | 952,000 |
| Dec 2025 | 0 | — | -3,351,000 | -30,799,000 | 82,937,000 | 8,758,000 | 1,087,000 |
| Sep 2025 | 0 | — | -3,108,000 | -3,639,000 | 113,337,000 | 10,113,000 | 1,068,000 |
| Jun 2025 | 0 | — | -2,878,000 | -2,688,000 | 18,285,000 | 18,011,000 | 1,354,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-10,418,000
Investing CF
$-97,333,000
Financing CF
$94,823,000
CapEx
—
Dividends Paid
$0
Buybacks
$-1,792,000
EPS Diluted TTM
$-1.99
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-462,296,000
Inventory
—
Receivables
—
ST Investments
$2,084,000
EBIT TTM
$-12,102,000
Pretax Income TTM
$-60,820,000
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Jun 2025 | 0 | -17,455,000 | -15,945,000 | 18,285,000 | 1,354,000 | — | -20,844,000 |
| Jun 2024 | 65,297,000 | 25,441,000 | 17,778,000 | 41,375,000 | 8,355,000 | — | -50,473,000 |
| Jun 2023 | 48,816,000 | -36,764,000 | -31,838,000 | 120,809,000 | 96,185,000 | — | -52,484,000 |
| Jun 2022 | 40,697,000 | -75,484,000 | -54,454,000 | 177,840,000 | 125,427,000 | — | -48,746,000 |
| Jun 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| DARE | Dare Bioscience, Inc. | $31.16M | $2.08 | — |
| BOLD | Boundless Bio, Inc. | $31.45M | $1.40 | — |
| NNVC | NANOVIRICIDES, INC. | $30.80M | $1.34 | — |
| APLM | Apollomics Inc. | $30.66M | $13.96 | — |
| ATNM | Actinium Pharmaceuticals, Inc. | $32.00M | $1.02 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.